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Abstract 
Substance abuse and aggression are significant problems in individuals with 
schizophrenia. Studies on populations other than schizophrenia have shown that people 
who engage in risk-taking behaviors are also more likely to abuse substances and engage 
in aggressive behaviors. In schizophrenia, however, it is unknown whether risk-taking 
traits underlie the abuse of substances and aggressive behavior, or if there are other 
underlying mechanisms that are driving the addictive and aggressive behaviors (e.g., 
psychosis. Identifying who are at risk for substance abuse and aggressive behavior can be 
beneficial for the individual and public. Our results showed that: 1) schizophrenia 
patients were more aggressive than healthy controls, but exhibited attenuated risk-taking 
as measured by the Balloon Analogue Risk Task; 2) only hostile aggression was related 
to risk-taking in the schizophrenia population; and, 3) patients with less psychopathology 
showed similar risk-taking performance to the controls. Our regression analysis 
demonstrated how risk-taking propensity is a decent predictor of aggressive behavior, in 
particular hostility. Most importantly, this study provides further evidence that 
schizophrenia patients exhibit a distinct pattern of risk-taking that may be modulated by 
their level of psychopathological symptoms, in particular their positive symptomatology. 
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Introduction 
Substance abuse and aggression are significant problems in individuals with 
schizophrenia. These individuals are 2-4 times more likely to be aggressive than people 
in the general population (Walsh et al., 2002), a risk that increases 8-fold with co-morbid 
substance abuse (Swanson et al., 2006) with 40 to 50% of patients suffering from a 
substance use disorder (Arkerele & Levin, 2002). These behaviors may have major 
implications on social functioning, such as poor treatment prognosis and increased 
number of hospitalizations (Tandon et al., 2008). Thus, being able to identify those who 
are at risk for substance abuse and aggressive behavior may have substantial benefits to 
both the individual and to the public  
Despite extensive research on the topic, it remains unclear who among people 
with schizophrenia are more likely to be both substance abusers and aggressive. Studies 
on populations other than schizophrenia have shown that people who engage in risk-
taking behaviors – activities that can be considered dangerous – are also more likely to 
abuse substances and engage in aggressive behaviors (Luejez et al, 2004). In 
schizophrenia, however, it is unknown whether risk-taking traits underlie the abuse of 
substances and aggressive behavior, or if there are other underlying mechanisms that are 
driving the addictive and aggressive behaviors (e.g., psychosis). Improving our 
understanding of the relationship between risk-taking, substance abuse and aggression in 
people with schizophrenia may inform novel treatments that target the aggression and 
substance abuse related symptoms. This knowledge may help to create treatment that not 
only targets the pathology, but also conforms to the specific way the patients asses risk as 
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they engage in substance abuse and aggression. Improvement in the overall efficacy of 
treatment may have a significant impact on their social functioning.  
Schizophrenia 
Schizophrenia is a severe mental disorder that affects 1.1% of the population -
approximately 3.2 million Americans and 24 million people worldwide (National 
Institute of Mental Health, 2009; World Health Organization, 2008). The disorder is 
characterized by a disintegration of cognitive and emotional processes that affect the 
individual’s behavior. The diagnostic features of schizophrenia are conceptualized into 
three broad categories: positive, negative and cognitive symptoms (Diagnostic Statistical 
Manual-IV-Text Revised, 2000). The positive symptoms include distortions in thoughts 
of reality (delusions), distortions in perceptions of stimuli (hallucinations), disorganized 
speech and thought disorder. Negative symptoms include flat affect, problems in 
producing speech and thought (alogia), lack of pleasure in everyday life (anhedonia), and 
lack of motivation (avolition). Cognitive symptoms include poor executive functioning 
(impaired ability to understand information and use it to make decisions) and trouble 
focusing and paying attention. These deteriorating symptoms may in some cases 
contribute to poor quality of life, functional disability and poor social functioning.  
Cognitive Deficits: Decision-Making and Reward Processing  
Schizophrenia patients suffer deficits across many areas of cognitive functioning; 
90% of patients suffer deficits in at least one area of cognition (Kern & Horan, 2010). 
Research has shown that patients suffer deficits especially in areas of decision-making 
and reward processing (Kester et al., 2006; Gold et al., 2008). Deficits in decision-
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making refer to failure to make rational optimal choices (Franken & Muris, 2005), and 
reward processing involves the valuing of a positive choice over a neutral or aversive 
consequence (Gold et al., 2008). Patients with impaired reward-based decision-making 
often pursue actions that bring some kind of immediate reward, despite severe long-term 
consequences such as the loss of job, home and family. (Franken & Muris, 2005).  
Both decision-making and reward processing are mediated through the orbital 
frontal cortex (OFC) (Rolls, 2000), which is located in the prefrontal lobe.  In patients 
with schizophrenia, structural abnormalities in the OFC have been related to poor 
performance on decision-making tasks (Kester et al., 2006; Shurman, Horan & 
Neuchterlein, 2005). The ability to make an educated decision – by assessing the value of 
a reward over punishment – is a central feature in the evaluation of a risky situation. 
When assessed with the Iowa Gambling Task, a task intended to simulate real-life 
decision-making processes with the evaluation of reward and punishment, schizophrenia 
patients have consistently performed significantly worse than controls (Kester et al. 2006; 
Shurman, Horan & Neuchterlein, 2005). The pattern of performance shows how patients 
repeatedly chose disadvantageous choices and failed to adjust their behavior to avoid 
punishment in the future.  This is consistent with Bechara et al.’s (1994) interpretation 
that patients with OFC abnormalities suffer from “myopia for the future,” responding to 
the immediate reinforces properties of the reward while failing to adjust their behavior to 
the punishments strategies.  
  In a review paper, Gold et al. (2008) suggest that impairment in decision-making 
processes in schizophrenia patients influence their ability to fully represent the value of 
different choices and compromises reward processing (Gold et al. 2008). In studies that 
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examines whether a person will have a preference for smaller immediate rewards over 
larger delayed rewards, schizophrenia patients have been found to discount value of 
future rewards more steeply than healthy subjects and chose smaller immediate rewards 
over larger delayed rewards (Heerey et al. 2007). This may suggest that patients with 
schizophrenia who discount rewards fail to fully weigh risk of losses when faced with 
potential gains (Heerey et al., 2008). 
Risk-Taking 
Risk taking is directly related to decision-making and reward processing. 
Individuals who are high-risk takers are more likely to have impaired decision-making 
and reward-processing systems. Risk-taking involves some probability of danger and also 
provides an opportunity for rewards (Whiteside & Lynam, 2003). Risk-taking behaviors 
are those that simultaneously involve high potential for danger or punishment and 
opportunity to obtain reward (Lejuez et al., 2002). It is possible that some people who 
engage in risk-taking behaviors are less concerned about the risk of injury than the 
potential rewards associated with the behaviors, and prefer immediate rewards as they 
engage in discounting.  
Several studies have shown a high correlation between risk taking propensity and 
substance abuse in both adolescents and adults (DiClemente,1993; Lejuez et al., 2005). 
Increased risk-taking – assessed by the balloon analogue risk task (BART), a 
computerized measure of risk-taking – is significantly related to behaviors such as 
alcohol and drug use, cigarette smoking, gambling, theft, aggression in both adolescents 
(Aklin, Luejez, Zvolensky, Kahler & Gwadz, 2005) and adult samples (Luejez, Simmons, 
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Aklin, Daughters & Dvir, 2004). Research has also shown that those more likely to 
engage in high-risk behavior tend to discount the value of delayed rewards at higher rate 
than other groups  (Murray et al., 2003). For example, Petry and Casarrela (1999) found 
that substance abusers with gambling problems discounted delayed rewards more steeply 
than substance abusers without gambling problems and a healthy control population; 
suggesting discounting of rewards as an important behavioral dimension of risk-taking.  
Risk-taking and Aggression 
Another aspect that underlies risk-taking is impulsivity. Individuals who engage 
in risky behaviors are often defined as impulsive, which involve a lack of control over 
one’s behavior with a tendency to act without thinking of the consequences. Impulsive 
individuals have difficulty in inhibiting responses and prefer immediate rewards to 
delayed rewards (Franken & Muris, 2005). Both, lack of control and steep discounting 
refer to different mechanism of impulsivity.  Impulsivity has previously been considered 
to have a significant role in criminal, antisocial and aggressive acts (Eysenck & 
Gudjonson 1989; Krakowski, 2005).  Research on psychopathic individuals 
(characterized by poor impulse control and aggressiveness) suggest that these individuals 
exhibit a significant tendency to engage in high-risk activities, such as violent behaviors, 
institutional misconduct, incarcerations and risky sexual activity (Buffington-Vollum, 
Edens, Johnson & Johnson, 2002). In a schizophrenia population, Kumari (2009) found 
that schizophrenia individuals with a high propensity for repetitive violence showed 
higher impulsivity levels, as measured by an impulsiveness scale, than schizophrenia 
patients without a history of violent behaviors and controls. The high rates of aggression 
and engaging in risky behaviors among a psychiatric population may contribute to a 
Running Head: RISK-TAKING IN SCHIZOPHRENIA 8 
negative social outcome in these individuals, such as incarceration, hospitalization, 
substance abuse and overall poor quality of life.  
Overall, as discussed above, there is a strong body of literature that links risk-
taking with aggression and substance abuse. There is empirical evidence on the 
prevalence of the relationship between these factors and negative outcomes in people 
with schizophrenia, a population at higher risk for aggressive behavior and substance 
abuse than the general population (Walsh et al,. 2002;Arkerele & Levin, 2002). 
Considering the negative psychological, legal and interpersonal consequences associated 
with high-risk behaviors (Luejez et al., 2004), it is important to further our understanding 
of the relationship between risk-taking traits and substance abuse and aggression in 
people with schizophrenia. However, to our knowledge, limited research has specifically 
examined this relationship in schizophrenia patients. As a matter of fact, we know very 
little about the underlying mechanism of risk-taking in schizophrenia. It remains unclear 
whether subgroups of “riskier” individuals are more likely to engage in substance abuse 
and aggression, or if other underlying mechanisms, such as psychosis, are driving these 
behaviors. The only literature that examines some form of risk-taking in schizophrenia 
patients focuses on impulsivity (Kumari et al. 2009; Hoptman et al. 2004). More 
importantly, these studies assessed impulsivity and risk-taking behaviors with self- report 
instruments. This has been shown to be problematic as individuals may not report actual 
risky behaviors out of fear of negative consequences (Luejez et al., 2002). There is a need 
for studies that explore this relationship using valid and more reliable behavioral 
measures that involve actual risk behavior. 
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The objective of the current study was to assess risk-taking propensity in 
schizophrenia patients and in healthy controls using a laboratory based measures that 
involve actual risky behaviors (the BART) and examine the association with substance 
abuse, aggression, and social functioning. Being able to identify those who are at risk for 
substance abuse and aggressive tendencies may have substantial benefits to individuals 
with schizophrenia. For the study we hypothesized: 
 
 (1) Increased risk-taking behavior (as measured by the BART) will be 
associated with substance abuse and poor social outcome in both 
experimental groups 
(2) Risk-taking behavior will be associated with aggressive behavior  
 (3) Individuals with schizophrenia will show lower levels of risk 
taking behavior than controls. 




Participants included 32 Schizophrenia patients and 10 healthy volunteers. 
Individuals diagnosed with schizophrenia disorder were recruited from outpatient mental 
health clinics from Bellevue Hospital Center. The diagnosis of schizophrenia was 
confirmed using the Structured Clinical Interview for DSM-IV (SCID) (Sptizer et al., 
1992). The 10 healthy controls were recruited as part of a Schizophrenia study recruited 
via advertisements placed on www.craigslist.com (a community classifieds and forums 
Website) and fliers posted at New York University Medical Center and Bellevue Hospital 
Center.  
The inclusion criteria required all participants to be between 18 and 55 years of 
age and to have English as their first language. The exclusion criteria for volunteers 
disqualified any participant with a family history of psychosis and or any lifetime Axis I 
diagnosis (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision, 2000). Volunteers were paid $10 per hour for their participation and were 
treated in accordance with the “Ethical Principles of Psychologist and Code of Conduct” 
(American Psychological Association, 1992). All participants provided written informed 
consent.  
Overall, 42 participants completed all baseline assessments. Schizophrenia 
patients (20 male and 12 females) had average mean age of 43.09 (sd=9.2) and a mean of 
12.81 years in education. 53% of patients were African American, 31% Caucasian, and 
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16% other race. Healthy Controls (7 male and 3 female) had an average mean age of 37 
(sd=9.5) and a mean of 14.80 years of education; where 60% were African American, 
20% Asian and 20% other race.   
2.Measures 
2.1 To assess Risk-taking 
Balloon Analog Risk Task (BART; Luejez et al.,2002). To asses risk taking, we 
administered the BART, which has successfully used to describe currently risk behaviors 
in adults (Luejez et al., 2002, 2003). It is a computerized experimental measure of 
propensity towards risk taking behavior. At the start of the BART, participants followed 
instructions on the screen that clearly explained the procedure of the task.  They are 
required to sequentially inflate a balloon that either will increase in size or explode. The 
game displayed four items: a small balloon accompanied by a balloon pump labeled 
“Press to Pump the balloon,” a reset button labeled “Press to Collect $$$,” a “Total 
Earned” display and a second display labeled “Last Balloon” that listed the money earned 
on the last balloon. A larger balloon is associated with increased risk for explosion, as 
well as increased reward. The participant earns $0.05 per “pump” and can “cash out”, 
stop pumping the balloon, at any time and click the “Collect $$$” button and the earned 
money is transferred into a “bank”. When balloons explode, all the money in the 
temporary bank is lost, and the next deflated balloon appears on the screen. A total of 30 
balloons (i.e. trials) are completed. If the balloon explodes, s/he loses the earned money 
(not the money in the bank). It is important to note that participants were given no precise 
information about the probability of explosion. Modeling real-world situations in which 
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excessive risk often produces diminishing returns and increasing threats to one’s health 
and safety, each successive pump on a particular balloon trial (a) increased  the amount to 
be lost due to an explosion and (b) decreased the relative gain of any additional pump.  
2.2 Assessment of Aggression 
Life History of Aggression (LHA; Coccaro, Berman & Kavoussi, 1997). A semi-
structured interview containing 11-items that assess a person’s aggressive and antisocial 
behavior in the past. The scale is comprised of three subscales: physical aggression, 
antisocial behavior, and self-directed aggression. Higher scores indicates higher levels of 
historical aggression. 
Aggression Questionnaire (AQ; Buss & Perry, 1992). An inventory of 29 self-
reported items assessing aggressive tendencies.  Its questions are in four domains: 
physical aggression, verbal aggression, anger, and hostility. Higher scores indicated 
higher levels of aggression.  
2.3 Assessment of Substance use and poor social functioning 
Diagnostic Interview of Genetic Studies (DIGS) was used to assess lifetime and 
current psychiatric diagnoses. It includes assessments for depression/dysthymia, 
mania/hypomania, alcohol/other drug abuse or dependence, suicidal behavior, violence, 
pathological gambling, antisocial personality disorder, and Global Assessment of 
Functioning.  
Positive and Negative Syndrome Scale (PANSS) is a 30 item instrument 
organized into five scales: Negative, Positive, Dysphoric Mood, Activation, and Autistic 
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Preoccupation. It evaluates the presence/absence and severity of positive, negative and 
general psychopathology of schizophrenia.  
World Health Quality of Life (WHOQOL) is a 26-item instrument that measures 
five conceptual domains of quality of life: material and physical well-being, relationships 
with other people, social, community and civic activities, personal development and 
fulfillment, and recreation. For the purpose of this study we only looked at the total score 
of the WHOQOL as a surrogate measure for overall level of social functioning.  
3. Procedures 
Participants were part of a larger study examining the relationship of 
schizophrenia symptoms and paternal age. Study procedures were approved by the New 
York University School of Medicine Institutional Review Board. All participants 
completed a standardized informed consent process with trained recruiters and were 
advised that a Federal Certificate of Confidentiality would protect their information. 
Participants completed the diagnostic interview first, and thereafter completed the 
remaining baseline assessments. The BART was administered last in the same clinical 
testing room as the other interviews.  





 Using t-test statistics, our analyses indicate that schizophrenia patients reported 
significantly higher levels of life history of aggression than controls (M=18.8, SD=11.1 
and M=7.1, SD=5.8, respectively, p < 0.05), as measured with the LHA scale. 
Schizophrenia patients also reported higher levels of current aggressive features 
compared to controls on the self-report AQ, (M=67. 2, SD= 22.1 and M=25.1 SD= 12.3, 
respectively, p = 0.001). Patients’ scores on the subscales of the two aggression measures 
were mostly significantly higher than controls, except for verbal aggression (see Table 2).  
 
Balloon Analogue Risk Tasks performance: 
The mean number of balloon inflations (average clicks across trials) on the BART 
was higher for controls (M=29. 7, SD=13. 1) than for patients (M=19.7, SD=10.9), p = 
0.03. The controls popped significantly more balloons (M=10 SD= 4.6) than the patients 
(M=6.2, SD= 3.7), p = 0.02. Overall, controls (32.33 USD) had a significantly higher 
average of earning than patients (24.41 USD), p < 0.05. 
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Correlational data 
There were no significant correlations in controls between the BART and the 
aggression measures. In patients, there was a significant positive correlation between 
self-reported hostility in the AQ with the average adjusted balloons inflations (r=0.48, 
p=0.01), the number of balloon pops (r= 0.47, p= 0.01), and earnings (r= 0.42, p= 0.02).  
When looking at the relationship between psychopathology, aggression and BART, our 
analysis focused only on schizophrenia patients. There was a significant positive 
correlation between the negative, activation, and autism symptoms subscales of the 
PANSS and the physical aggression on the AQ (p<0.05 for all). There was also a 
significant correlation between the PANSS activation subscale and AQ verbal aggression, 
anger, and total aggression (p<0.01 for all). The positive symptoms of psychopathology 
were also negatively correlated with both the averages adjusted balloon inflations (r=-
0.39, p=0.03), the number of balloon pops (r=-0.36, p= 0.04), and earnings (r= -0.38, p= 
0.03). There was no significant correlation of the LHA  and risk taking as measured by 
the BART in controls or patients.  
 
Substance Abuse, Psychopathology, Aggression, and Risk Taking 
Sixty-six percent of the patients (21 of 32) met criteria for a history of substance 
abuse, whereas no controls reported any substance abuse. Patients with a history of 
substance abuse showed a higher rate of total aggression on the AQ (t=-2.13, p=0.04), as 
well as the AQ physical and anger subscales (p<0.05), compared to patients without a 
history of substance abuse. Additionally, patients with substance abuse histories reported 
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significantly higher life history of aggression; antisocial aggression, physical aggression, 
and total history of aggression (p<0.05). There was no significant difference in 
performance on the BART for the substance versus no substance abuse groups. Those 
with a history of substance abuse scored significantly higher on the total psychopathology 
scale (t=-2.11, p=0.04). 
 
BART, Aggression, and Quality of Life in Patients 
 In follow up analyses we explored the relationship between BART variables and 
Quality of Life as a measure how risk taking and aggression may influence patients’ daily 
life. BART average earnings and average inflations were negatively correlated with total 
quality of life (p<0.05), indicating that those who demonstrated more risk taking had 
poorer daily life functioning. Quality of life was also negatively correlated with total 
aggression and hostility on the AQ (p<0.01). Those patients with histories of substance 
abuse demonstrated a trend towards poorer quality of life (t=1.97, p=0.06); no difference 
was found between substance groups on BART variables and AQ hostility, although 
there was a significant difference for total AQ aggression (t=-2.13, p=0.04).  
Regression Analyses 
 Due to our findings above, we conducted hierarchical linear multiple regression 
analyses to examine the predictability of BART average inflations, quality of life, 
substance abuse, positive psychopathological symptoms on AQ total aggression and 
hostility. In both analyses, demographics (sex, education, substance abuse) were first 
entered, then quality of life and positive symptoms in the second step, before entering 
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BART average inflations in the third step to see if risk taking predicted aggression over 
and above other variables (dependent variables were total aggression [analysis 1] and 
hostility [analysis 2]). The results indicated that quality of life and average inflations 
accounted for a significant amount of the total aggression (R2=0.34, F (1, 21) = 5.62, 
p=0.01), without other variables significantly contributing. However, the quality of life 
variable predicted over and above the average inflations variable and accounted for close 
to 34% (of 34% total) of the total aggression variance. Similarly, our results indicated 
that quality of life and average inflations accounted for a significant amount of the 
hostility as well (R2=0.46, F(1, 21) = 9.01, p=0.002), without other variables significantly 
contributing. The quality of life variable predicted over and above the average inflations 
variable and accounted for approximately 40% of the variance, and the average inflations 
variable added another 6% to the variance. Based on our results, risk taking as measured 
with the BART average inflations, in combination with current quality of life, is a decent 
predictor of aggression, in particular hostility.     




















 We investigated the relationship of risk-taking, aggression, and substance abuse in 
schizophrenia and healthy controls. To our knowledge, this study represents the first 
report of the BART administered in a schizophrenia population. The three major findings 
of our study are: 1) schizophrenia patients were more aggressive than healthy controls, 
but exhibited attenuated risk-taking as measured by the BART; 2) only hostile aggression 
was related to risk-taking in the schizophrenia population; and, 3) patients with less 
psychopathology showed similar risk-taking performance to the controls.     
 Consistent with the literature on aggression and substance abuse in schizophrenia 
(Walsh et al., 2002; Arkel & Levin, 2002), we found a high rate of patients with 
substance abuse and they were significantly more aggressive than controls. Although 
higher in aggression, patients exhibited attenuated risk taking as measured with the 
BART, a computer task that assesses risk-taking propensity. Controls showed higher risk-
taking as they had higher inflations and monetary earnings than the patients. These 
findings can be at first glance surprising given the line of research that suggests an 
association between high risk taking and aggressive and addictive behavior in non-
schizophrenia populations. (Luejez et al., 2002; Aklin et al., 2005). However, our results 
support our hypothesis that patients would show lower risk taking than controls and is 
supported by literature suggesting a distinct pattern of decision-making in people with 
schizophrenia (Shurman et al., 2005), as well as deficits in reward processing (Gold et al., 
2008).  
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Our results showed that patients popped significantly less balloons than controls, 
but earned less money. This pattern of performance may suggest a different reward 
processing in the schizophrenia group than the healthy controls. The displacement of the 
value of the reward is apparent as they had a consistent focus on popping less balloons 
than on gaining more money.  This is consistent Gold’s (2008) literature review  that 
decision-making in patients appear to be compromised by deficits in the ability to fully 
weight the value of a different choices.  
Moreover, consistent with our hypothesis, there was evidence of a significant 
association between risk-taking and aggression in patients. Although we expected to be a 
stronger correlation across all measures of aggression, it was only significant in the self-
reported hostility in the AQ (r=0.47, p=0.01). The higher the hostility, the higher the total 
earned money, average inflations, and number of balloon pops. Hostility, which consists 
of feelings of ill will and injustice, represents the cognitive component of behavior (Buss 
& Perry, 1992). Therefore, it is interesting that only the cognitive component of 
aggression and not the actual physical or preparation of aggression showed a link with 
behavioral risk-taking performance. Given that literature supports a different pattern of 
decision-making for schizophrenia patients (Kester et al., 2006); these results highlight 
the importance of looking into the decision-making aspect of taking the risk. Despite 
strong correlation between both aggression measures, there was no significant correlation 
of LHA and the risk taking as measured by the BART in controls or patients. This may be 
because the LHA measures lifetime aggressions, whereas the AQ focuses on self-reported 
current aggressive features.  
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When examining substance abuse in patients, the results showed no significant 
difference in performance on the BART for the substance abuse vs. no substance abuse 
groups. However, consistent with the literature on substance abuse and aggression in 
schizophrenia (Swason et al., 2006), the patients with a history of substance abuse 
showed a higher total aggression in comparison to the patients without a history of 
substance abuse.   
One of the most interesting results in this study came as we examined the 
relationship of risk-taking performance and the severity of psychopathology (PANSS) in 
patients. The negative correlation between the positive symptoms of psychopathology 
and higher risk-taking yielded interesting interpretation for the pattern of performance in 
the schizophrenia population. The less positive symptoms the patient reported, the higher 
the monetary earnings and adjusted inflations. In other words, less positive 
psychopathology was associated with risk-taking behavior similar to the healthy controls. 
This finding supports the idea that the psychopathology is indeed interfering with the 
patient’s ability to process risk-taking in a similar manner as the healthy population. The 
impairment in cognitive functions, compromised decision-making and reward process is 
attributed in other studies to the patient’s poor performance on other computerized risk-
taking task (Kester, et al., 2006). Our results provides further evidence that schizophrenia 
patients exhibit a distinct pattern of risk taking that may be modulated by their level of 
psychopathological symptoms, in particular their positive symptomatology.  
In our follow up analyses that examined the influence of risk taking in a patient’s 
daily life, our results were consistent with our predictions that those who demonstrated 
more risk taking had a poorer daily life functioning. These findings support the line of 
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literature that highlight how engaging in risk-taking behavior contribute to negative 
social outcomes such as incarceration and hospitalizations (Hunt et al., 2010). To further 
explore this in combination with substance abuse and aggression, we conducted a 
regression analysis, in which we demonstrated that current life quality and risk taking 
propensity is a decent predictor of aggressive behavior, in particular hostility. This may 
not be surprising as the hostility items consist of items that correspond to sensation-
seeking content that trigger the behavior (Buss & Perry, 1992).  
In summary, the lack of research exploring the relations among behavioral risk 
taking, aggression, substance abuse and life quality in schizophrenia make the results of 
the study particularly intriguing. In future research, it will be important to further specify 
how symptomatology influences performance of risk-taking. It would be helpful to 
collect a verbal report of the patient’s experience and decision-making strategies while 
performing the BART. In addition, it will be important to complement with self-report 
measures designed to assess related conducts. Such programs of research will help to 
elucidate theoretical models and clinical correlates of schizophrenia, which may result in 
increased understanding of the way patients make decisions about risky situations and 
thus reducing the negative consequences of the behavior.  
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Table 1. Demographic and Clinical Information 
  
 Schizophrenia (n=32) Control (n=10) Statistic 
Age in years 43.09 (9.2) 37.00 (9.5) NS 
Education in years 12.81 (2.4) 14.80 (2.3) t = 2.3, p = 0.03 
Sex (male/female) 20/12 7/3 NS 
Race/ethnicity   χ2 (5, n = 42) = 
12.01, p = 0.03 
Caucasian 12 0  
Black 17 8  
Asian/Pacific Islander 0 2  
Native American 1 0  
Other/more than one 
race 
2 0  
Hispanic/non-Hispanic 5/27 3/7 NS 
Diagnosis (schizophrenia/ 
schizoaffective disorder) 
28/4 -- -- 
Substance Abuse (yes/no) 22/10 0/10 χ2 (n = 42) = 
14.43, p < 0.01 
PANSS    
Total 58.73 (14.7) -- -- 
Positive 10.80 (4.5) -- -- 
Negative 16.33 (5.2) -- -- 
Activation 8.73 (2.1) -- -- 
Dysphoria 12.30 (5.5) -- -- 
Autism 10.56 (3.3) -- -- 
Standard deviations appear in parentheses
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Table 2. Aggression and BART data. 
 Schizophrenia (n=32) Control (n=10) Statistic 
Life History of Aggression    
      Total 18.8 (11.1) 7.1   (5.8) t = -3.0, p = 0.05 
     Physical Aggression 11.93 (7.1) 4.66 (3.6) t = -2.9, p = 0.05 
Antisocial Aggression 5.5 (2.4) 2.44 (3.8) t = -1.7, p = 0.66 
Self-Directed 
Aggression 1.31 (1.3) 0 (0.0) 
t = -2.8, p = 
0.06 
Buss Perry Aggression 
Questionnaire    
Total 67.2 (22.1) 52.0 (12.8) t = -2.3, p = 0.03 
Physical Aggression 20.4 (8.1) 14.4 (5.5) t = -3.3, p = 0.02 
Verbal Aggression 12.4 (5.5) 13.0 (6.4) NS 
Anger 14.1 (5.5) 11.7 (4.0) NS 
Hostility 20.4 (7.9) 12.8 (6.1) t = -2.6, p = 0.02 
BART    
Adjusted number of 
balloons inflations across 
trial 
19.7 (10.9) 29.7 (13.1) t = 2.2, p = 0.03 
Balloons pops 10 (4.6)  6.3 (3.7) t = 2.4, p = 0.02 
Average Earning 24.4 (11.7) 32.09 (11.9) t = 1.7, p = 0.08 
Standard deviations appear in parentheses  
 
 
  
